A clinical trial to study the effects of two drugs, Metformin Immediate Release and Metformin Extended Release in newly diagnosed type 2 diabetes mellitus patients.
Phase 4
Completed
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2021/04/033194
- Lead Sponsor
- Bangalore Medical College and Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
1.Newly diagnosed Type 2 Diabetes Mellitus Patients as per American Diabetes Association guidelines.3
2.Patients of either sex aged �18years to �60 years.
3.Patients willing to give written informed consent.
Exclusion Criteria
1.Newly diagnosed Type 2 diabetes mellitus patients with glycemic markers HbA1C >8.5, FBS >160mg/dl, PPBS > 260mg/dl.
2.Patients suffering with any other co-existing medical illness.
3.Patients not willing to give written informed consent.
4.Women who were pregnant or breastfeeding.
5.Patients with serum creatinine level > 1.2 mg/dl.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method